1. Myocardial perfusion imaging: a plus for coronary risk classification in diabetics

   • Albert Flotats

   Editorial Commentary 31 January 2012 Pages: 383 - 386

2. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial

   • Wanda Acampa
   • Mario Petretta
   • Alberto Cuocolo

   Original Article 23 November 2011 Pages: 387 - 395

   

3. Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice

   • M. Hacker

   Editorial Commentary 22 December 2011 Pages: 396 - 398

4. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers

   • Yen-Wen Wu
   • Hsian-Li Kao
   • Wei-Shiung Yang

   Original Article 23 November 2011 Pages: 399 - 407

   

5. The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure

   • Georg Goliasch
   • Aliasghar Khorsand
   • Senta Graf

   Original Article 15 November 2011 Pages: 408 - 415

   

6. Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy

   • Matthias Paul
   • Kambiz Rahbar
   • Michael Schäfers

   Short Communication 24 November 2011 Pages: 416 - 420

   

7. Ventricular dyssynchrony assessed by gated myocardial perfusion SPECT using a geometrical approach: a feasibility study

   • Berlinda J. van der Veen
   • Imad Al Younis
   • Albert de Roos

   Original Article Open access 24 November 2011 Pages: 421 - 429

   

8. Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device

   • Michael Fiechter
   • Jelena R. Ghadri
   • Philipp A. Kaufmann

   Original Article 06 December 2011 Pages: 430 - 436

   

9. ST-segment depression during vasodilator stress is of minor clinical importance in women with normal myocardial perfusion imaging and low or intermediate risk of coronary artery disease

   • Dimitris J. Apostolopoulos
   • Periklis Davlouros
   • Dimitrios Alexopoulos

   Original Article 08 December 2011 Pages: 437 - 445

   

10. Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?

    • Laura Evangelista
    • Domenico Rubello
    • Giorgio Saladini

    Editorial Commentary 20 December 2011 Pages: 446 - 449

11. Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study

    • Nina Mortazavi-Jehanno
    • Anne-Laure Giraudet
    • Jean-Louis Alberini

    Original Article 20 December 2011 Pages: 450 - 460

    

12. ¹⁸F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?

    • Otto C. Boerman
    • Martin Gotthardt

    Editorial Commentary Open access 15 December 2011 Pages: 461 - 462

13. ¹⁸F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma

    • Dale O. Kiesewetter
    • Haokao Gao
    • Xiaoyuan Chen

    Original Article 15 December 2011 Pages: 463 - 473

    

14. Prognostic significance of mediastinal ¹⁸F-FDG uptake in PET/CT in advanced ovarian cancer

    • Anne-Sophie Bats
    • Florent Hugonnet
    • Fabrice Lécuru

    Original Article 23 November 2011 Pages: 474 - 480

    

15. Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with ¹¹¹In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts

    • Jennie Malmberg
    • Anna Perols
    • Amelie Eriksson Karlström

    Original Article 30 November 2011 Pages: 481 - 492

    

16. ¹⁸F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation

    • Thorsten Derlin
    • Christoph Weber
    • Nicolaus Kröger

    Original Article 24 November 2011 Pages: 493 - 500

    

17. Comparison of sequential planar ¹⁷⁷Lu-DOTA-TATE dosimetry scans with ⁶⁸Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

    • Aurora Sainz-Esteban
    • Vikas Prasad
    • Richard P. Baum

    Original Article 20 December 2011 Pages: 501 - 511

    

18. Biodistribution, radiation dosimetry and scouting of ⁹⁰Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using ⁸⁹Zr-ibritumomab tiuxetan and PET

    • Saiyada N. F. Rizvi
    • Otto J. Visser
    • Mark Lubberink

    Original Article Open access 05 January 2012 Pages: 512 - 520

    

19. ¹⁸F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials

    • Thida Win
    • Tryphon Lambrou
    • Ashley M. Groves

    Original Article 30 November 2011 Pages: 521 - 528

    

20. Extremity doses of nuclear medicine personnel: a concern

    • Gerrit J. Kemerink
    • Filip Vanhavere
    • Felix M. Mottaghy

    Editorial Open access 15 November 2011 Pages: 529 - 532

21. Imaging the islet graft by positron emission tomography

    • Olof Eriksson
    • Abass Alavi

    Review Article 20 September 2011 Pages: 533 - 542

    

22. Functional imaging in phaeochromocytoma and neuroblastoma with ⁶⁸Ga-DOTA-Tyr³-octreotide positron emission tomography and ¹²³I-metaiodobenzylguanidine: a clarification

    • Alexander Kroiss
    • Daniel Putzer
    • Irene Johanna Virgolini

    Letter to the Editor 12 January 2012 Pages: 543 - 543

23. Suggested pathway to assess radiation safety of ¹¹C-labeled PET tracers for first-in-human studies

    • Paolo Zanotti-Fregonara
    • Robert B. Innis

    Letter to the Editor 08 December 2011 Pages: 544 - 547

24. Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail

    • Sauli Savolainen
    • Mark Konijnenberg
    • Glenn Flux

    Letter to the Editor 13 January 2012 Pages: 548 - 549

25. Razelle Kurzrock, Maurie Markman (eds): Targeted Cancer Therapy

    • Luigi Mansi
    • Andrea Vaccaro

    Book Review 05 October 2011 Pages: 550 - 551

26. Erratum to: Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

    • Angelina Cistaro
    • Maria Consuelo Valentini
    • Marco Pagani

    Erratum 16 December 2011 Pages: 552 - 552

27. ¹⁸F-FDG PET to identify soft tissue disease in multiple myeloma

    • Sharon F. Hain
    • Sobia Khan
    • William Stevenson

    Image of the Month 14 October 2011 Pages: 553 - 554